BR9600341A -
Compound process to produce the same pharmaceutical composition process to antagonize hormone releasing gonadotropin and use of the compound
- Google Patents
Compound process to produce the same pharmaceutical composition process to antagonize hormone releasing gonadotropin and use of the compound
Info
Publication number
BR9600341A
BR9600341ABR9600341ABR9600341ABR9600341ABR 9600341 ABR9600341 ABR 9600341ABR 9600341 ABR9600341 ABR 9600341ABR 9600341 ABR9600341 ABR 9600341ABR 9600341 ABR9600341 ABR 9600341A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries LtdfiledCriticalTakeda Chemical Industries Ltd
Priority claimed from PCT/JP1995/000728external-prioritypatent/WO1995028405A1/en
Priority claimed from JP09106895Aexternal-prioritypatent/JP3854648B2/en
Publication of BR9600341ApublicationCriticalpatent/BR9600341A/en
BR9600341A1995-02-081995-04-14
Compound process to produce the same pharmaceutical composition process to antagonize hormone releasing gonadotropin and use of the compound
BR9600341A
(en)
Compound use of a compound process for the treatment of pharmaceutical composition conditions processes for preparing a pharmaceutical composition and for preparing a compound
Preparation of monoclonal antibody for administration to a human pharmaceutical formulation use of a monoclonal antibody preparation and process for the manufacture of a monoclonal antibody preparation